Follow

Promore Pharma AB

Nasdaq First North GM (Sweden)

Promore Pharma AB is a biopharmaceutical company specialized in the development of therapeutic peptides. Promore Pharma's two projects are in late stage clinical development phase and have a very strong safety profile based on innate substances that are administered locally. The project, PXL01, that will be used for prevention of post-surgical adhesions and scars, is being prepared for clinical phase III-studies in patients undergoing tendon repair surgery in the hand. LL-37 has been recently evaluated in a Promore Pharma AB is a biopharmaceutical company specialized in the development of therapeutic peptides. Promore Pharma's two projects are in late stage clinical development phase and have a very strong safety profile based on innate substances that are administered locally. The project, PXL01, that will be used for prevention of post-surgical adhesions and scars, is being prepared for clinical phase III-studies in patients undergoing tendon repair surgery in the hand. LL-37 has been recently evaluated in a clinical phase IIb study in patients with venous leg ulcers (VLU). Read more

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Rights issue
Price
2.00 SEK
Subscription period
03 Jun - 17 Jun 2021
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
PROMO
SE0009947740
Nasdaq First North GM
Sweden (SE)
Details of share in Promore Pharma AB with ticker PROMO
Status
Active
Order book id
Amount of instruments
36 428 362
Par value
0.0400
Currency
SEK
Segment
First North
First trading date
03 Jul 2017
Type
Price
Pre-money
Time
Files
IPO
23.30 SEK
395.48M SEK
08 Jun - 22 Jun 2017
IPO in Promore Pharma AB
Type
Price
Pre-money
Time
Files
Exercise
23.30 SEK
21 Jan - 31 Jan 2019
Option exercise terms for PROMO TO1
Type
Price
Pre-money
Time
Files
Rights issue
3.71 SEK
75.07M SEK
13 Nov - 28 Nov 2019
Share issue in Promore Pharma AB
Type
Price
Pre-money
Time
Files
Rights issue
2.00 SEK
72.86M SEK
03 Jun - 17 Jun 2021
Share issue in Promore Pharma AB
Type
Ticker
ISIN
Market
SHARE
PROMO
SE0009947740
Nasdaq First North GM
Sweden (SE)
Details of share in Promore Pharma AB with ticker PROMO
Status
Active
Order book id
Amount of instruments
36 428 362
Par value
0.0400
Currency
SEK
Segment
First North
First trading date
03 Jul 2017
Type
Price
Pre-money
Time
Files
IPO
23.30 SEK
395.48M SEK
08 Jun - 22 Jun 2017
IPO in Promore Pharma AB
Type
Price
Pre-money
Time
Files
Rights issue
3.71 SEK
75.07M SEK
13 Nov - 28 Nov 2019
Share issue in Promore Pharma AB
Type
Price
Pre-money
Time
Files
Rights issue
2.00 SEK
72.86M SEK
03 Jun - 17 Jun 2021
Share issue in Promore Pharma AB
Type
Ticker
ISIN
Market
OPTION
PROMO TO1
SE0009997158
Nasdaq First North GM
Sweden (SE)
Details of option in Promore Pharma AB with ticker PROMO TO1
Status
Archived
Order book id
140252
Amount of instruments
6 523 560
Currency
SEK
Segment
First North
Trading period
06 Jul 2017 - 20 Feb 2019
Terms
Three (3) warrants entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to 70 percent of a volume weighted average trading price during the period from January 21, 2019 - January 31, 2019, but not less than SEK 23.30 and not more than SEK 46.60 per share. Subscriptions with the support of warrants will take place during the period from February 4, 2019 - February 22, 2019.
Update (04.07.2017): New equity right for trading in Promore Pharma AB.
Update (04.07.2017): Subscription price for warrants TO1 determined - SEK 23.30.
Type
Price
Pre-money
Time
Files
Exercise
23.30 SEK
21 Jan - 31 Jan 2019
Option exercise terms for PROMO TO1
People
Jonas Ekblom
CEO
Göran Pettersson
Chairman of the board
Göran Linder
Board member
Torsten Goesch
Board member
Satyendra Kumar
Board member
Marianne Dicander Alexandersson
Board member
Kerstin Valinder Strinnholm
Board member
Company Details
Sector
HEALTH CARE

Address
Fogdevreten 2
Zip code
171 65
City/district
Solna
Country
Sweden (SE)
Registration number
556639-6809
LEI code
549300FJYXYRTU6R3M15
First trade date
03 Jul 2017
Registration date
29 Jan 2003
Short name
Promore

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More